ModernMedicine Resource Center More Topics

Hot Topics in Prostate Cancer

mpMRI could reduce biopsies, improve diagnosisUsing multi-parametric magnetic resonance imaging to triage men with high serum PSA could save about one-fourth of patients from having transrectal ultrasound-guided prostate biopsy, according to a recent study.
Adding hormone therapy to salvage RT found efficaciousThe addition of hormonal therapy in post-RP is “practice changing,” study author says.
PCa: Emotional distress influences treatment decisionResearchers have found that the anxiety men often experience after being diagnosed with prostate cancer could lead to potentially unnecessary treatment options.
Laser-activated PCa therapy promising in phase III studyResearchers evaluate an experimental treatment called vascular-targeted photodynamic therapy in men with localized prostate cancer.
Mathematical model may predict PCa tumor growth, evolutionThe novel tool could result in earlier prostate cancer diagnoses and less invasive testing, although a prostate cancer expert cautioned that the model makes multiple assumptions and has not been validated.
Nomogram helps predict biochemical failure risk post RPUse of the nomogram, along with factors such as PSA level and family history, is a reliable, useful tool for helping urologists and their patients make better treatment decisions, says the author of a recent study.
Has ordering of PSA screening dropped among PCPs?An examination of data involving more than 63,000 PSA tests ordered by primary care physicians reveals some surprising findings.
Upbringing, socioeconomic status linked to PCaA recent study shows children born to high-status parents have a higher incidence rate of developing prostate and other cancers in later life.
Delay from biopsy to RP: Who is at risk of recurrence?The risk of prostate cancer relapse after radical prostatectomy increases with lengthening delay between diagnosis and surgery. The impact, however, is significant only in high-risk patients, and even in those men, there may be a window of up to 12 months during which it may be relatively safe to postpone surgery, reported researchers from Milan, Italy.
There’s something about PSA: Ben Stiller fights the good fightUrologist Henry Rosevear, MD, discusses actor Ben Stiller's recent blog post that credits PSA tests for saving his life after he was diagnosed with prostate cancer and the urologic community's surprising reaction to the article.